Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
In a prospective, randomized case-controlled study, the investigators hope to demonstrate a
positive correlation of plasma levels of EPA and DHA as well as fish intake with the
HbA1c-lowering effect of sitagliptin but not with the active comparator glimepiride.